Taken together, our results can reconcile different and apparently contrasting results on the role of Notch1 in prostate cancer and suggest that Notch1 inhibition as therapy for this malignancy should be carefully contextualized by analyzing Notch1 expression in cancer cells and in their surrounding microenvironment. This evidence concerns the gene NOTCH1 and prostate cancer.